Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Sutherland

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Nucleic Acids Research|December 11, 1994
Phosphorylation of the c-Fos and c-Jun HOB1 motif stimulates its activation capacityA J Bannister, H J Brown, J A Sutherland, et al.
American Journal of Obstetrics and Gynecology|April 15, 1980
Ultrastructure and steroid-binding studies in leiomyomatosis peritonealis disseminataJ A Sutherland, E A Wilson, D E Edger, et al.
The EMBO Journal|January 3, 1995
An inhibitor domain in c-Fos regulates activation domains containing the HOB1 motifH J Brown, J A Sutherland, A Cook, et al.
Journal of Biological Response Modifiers|June 1, 1986
Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineagesJ A Sutherland, A R Turner, P Mannoni, et al.
The Journal of Biological Chemistry|May 24, 1996
DAB389 interleukin-2 receptor binding domain mutations. Cytotoxic probes for studies of ligand-receptor interactionsJ C vanderSpek, J A Sutherland, M Ratnarathorn, et al.
Cancer Research|January 15, 1997
Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin-related fusion protein DAB389 GRPJ C vanderSpek, J A Sutherland, H Zeng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
Genetic construction and properties of a diphtheria toxin-related substance P fusion protein: in vitro destruction of cells bearing substance P receptorsC E Fisher, J A Sutherland, J E Krause, et al.
Molecular and Cellular Biology|September 1, 1994
c-Fos-induced activation of a TATA-box-containing promoter involves direct contact with TATA-box-binding proteinR Metz, A J Bannister, J A Sutherland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Therapy of untreated acute myeloid leukemia in the elderly: remission-induction using a non-cytarabine-containing regimen of mitoxantrone plus etoposideE J Bow, J A Sutherland, M G Kilpatrick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 1998
Single-agent high-dose melphalan salvage therapy for Hodgkin's disease: cost, safety, and long-term efficacyD A Stewart, D Guo, J A Sutherland, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Nucleic Acids Research|December 11, 1994
Phosphorylation of the c-Fos and c-Jun HOB1 motif stimulates its activation capacityA J Bannister, H J Brown, J A Sutherland, et al.
American Journal of Obstetrics and Gynecology|April 15, 1980
Ultrastructure and steroid-binding studies in leiomyomatosis peritonealis disseminataJ A Sutherland, E A Wilson, D E Edger, et al.
The EMBO Journal|January 3, 1995
An inhibitor domain in c-Fos regulates activation domains containing the HOB1 motifH J Brown, J A Sutherland, A Cook, et al.
Journal of Biological Response Modifiers|June 1, 1986
Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineagesJ A Sutherland, A R Turner, P Mannoni, et al.
The Journal of Biological Chemistry|May 24, 1996
DAB389 interleukin-2 receptor binding domain mutations. Cytotoxic probes for studies of ligand-receptor interactionsJ C vanderSpek, J A Sutherland, M Ratnarathorn, et al.
Cancer Research|January 15, 1997
Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin-related fusion protein DAB389 GRPJ C vanderSpek, J A Sutherland, H Zeng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
Genetic construction and properties of a diphtheria toxin-related substance P fusion protein: in vitro destruction of cells bearing substance P receptorsC E Fisher, J A Sutherland, J E Krause, et al.
Molecular and Cellular Biology|September 1, 1994
c-Fos-induced activation of a TATA-box-containing promoter involves direct contact with TATA-box-binding proteinR Metz, A J Bannister, J A Sutherland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Therapy of untreated acute myeloid leukemia in the elderly: remission-induction using a non-cytarabine-containing regimen of mitoxantrone plus etoposideE J Bow, J A Sutherland, M G Kilpatrick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 1998
Single-agent high-dose melphalan salvage therapy for Hodgkin's disease: cost, safety, and long-term efficacyD A Stewart, D Guo, J A Sutherland, et al.
Pageof 3